Kim A Reiss (Reiss Binder)

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Assistant Program Director , Hematology/Oncology Fellowship at University of Pennsylvania
Member, Abramson Cancer Center
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-360-0735
Fax: 215-662-4646
Education:
BA (Psychology)
Colby College, 2002.
Post BA (Pre-Med)
Johns Hopkins University , 2003.
MD (Medicine)
Penn State College of Medicine , 2008.
Permanent link
 

Description of Itmat Expertise

Clinical trials in gastrointestinal malignancies with a focus in pancreatic cancer and DNA repair pathways.

Selected Publications

William Chapin, MD; Mark O'Hara, MD; Kim Reiss Binder, MD; Erica Carpenter, PhD: Presence of circulating tumor cells detected by immunofluorescence staining and bioinformatics approach associated with worse overall survival in locally advanced and metastatic pancreatic cancer cohorts. University of Pennsylvania Department of Medicine Research Day June 2018.

James J. Harding, Joseph P. Erinjeri, Ben Tan, Kim A. Reiss Binder, Kabir Mody, Danny N. Khalil, Hooman Yarmohammadi, Gregory, Nadolski, Marinela Capanu, Richard K. Do, Michaela Bradley, Chayma Boussayoud, Emily Valentino, William R. Jarnagin, Michael C. Soulen, Karen T. Brown, Ghassan K. Abou-Alfa.: A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC). ASCO Annual Meeting, Chicago, IL June 2018.

Ofer Margalit, Ronac Mamtani, Scott Kopetz, Yu-Xiao Yang, Yaacov Richard Lawrence, Samir Abu-Gazala, Kim Anna Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce J. Giantonio, Einat Shacham-Shmueli, Ben Boursi: Refining the use of adjuvant oxaliplatin in clinical stage II or III rectal adenocarcinoma. ASCO Annual Meeting, Chicago, IL June 2018.

Brittany Bauman, Eileen Martinez, Theresa Lawless, Lindsey Zinck, Paige Madison, Mary Fuhrer, Ursina Teitelbaum, Mark O’Hara, Charles Schneider, Peter O’Dwyer, John P. Plastaras, Rosemarie Mick, Kim A. Reiss Binder : A Randomized Study to Establish the Efficacy of Oral Cryotherapy During Oxaliplatin Infusion in Preventing Oral Thermal Hyperalgesia. University of Pennsylvania Department of Medicine Research Day June 2018.

Ofer Margalit; Ronac Mamtani; Yu-Xiao Yang; Kim A Reiss; Talia Golan; Naama Halpern; Dan Aderka; Bruce Giantonio; Einat Shacham-Smueli; Ben Boursi: A new look at the IDEA classification - defining novel predictive and prognostic markers in stage III colon cancer. European Journal of Cancer June 2018.

Emily Shiffer: Pancreatic Cancer Symptoms. https://www.prevention.com/health/health-conditions/a20167615/pancreatic-cancer-symptoms/ Prevention Magazine, May 2018.

Ofer Margalit, MD, PhD; Ronac Mamtani, MD, MSC; Yu-Xiao Yang, MD, MSCE; Kim A. Reiss, MD; Talia Golan, MD; Naama Halpern, MD; Dan Aderka, MD; Bruce Giantonio MD; Einat Shacham-Shmueli MD; and Ben Boursi, MD: Assessing the Prognostic Value of CEA Levels in Stage I and II Colon Cancer. European Journal of Cancer May 2018.

Sriram Venigalla, Amit Chowdhry, Andrzej Wojcieszynski, Edgar Ben-Josef, Jacob Shabason, James Metz, John Plastaras, John Nicholas Lukens, Kim Reiss, Najjia Mahmoud: Comparative Effectiveness of Neoadjuvant Chemoradiation versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer. Clinical Colorectal Cancer May 2018.

Jacob Ezra Shabason, MD; Jerry Chen; Smith Apisarnthanarax, MD; Nevena Damjanov, MD; Bruce Giantonio, MD; Arturo Loaiza-Bonilla, MD; Peter J O’Dwyer, MD; Mark O’Hara, MD; Kim A Reiss, MD; Ursina Teitelbaum, MD; Paul Wissel, MD; Jeffrey Drebin, MD, PhD; Charles Vollmer, MD; Michael Kochman, MD; Rosemarie Mick; Norge Vergara, MD; Nirag Jhala, MD; Abigail Doucette; John N Lukens, MD; John P Plastaras, MD, PhD; James M Metz, MD; Edgar Ben-Josef, MD: A Phase I Dose Escalation Trial of Nab-Paclitaxel and Fixed Dose Radiation in Patients with Unresectable or Borderline Resectable Pancreatic Cancer. Cancer Chemotherapy and Pharmacology Mar 2018.

Baumann BC, Wei J, Plastaras J, Lukens J, Damjanov N, Hoteit M, Hsu C, Levine M, Mondschein J, Nadolski G, Olthoff K, Reiss K, Rosen M, Siegelman E, Metz J, Ben-Josef E. : Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control with Low Toxicity. American Journal of Clinical Oncology Mar 2018.

back to top
Last updated: 08/13/2018
The Trustees of the University of Pennsylvania